Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8479134 | Neurochemistry International | 2015 | 14 Pages |
Abstract
Unexpectedly, prolonged delivery of C3 and C3156â181 at the lesion site did not increase the outcome of PNR. Regarding the potential mechanism underlying their previously detected PNR promoting action, however, 6 genes were found to be commonly altered in SCs upon treatment with C3 or C3156â181. We demonstrate significant down-regulation of genes involved in glutamate uptake (Eaac1,5Grin2a6) and changes in neurotrophic factor expression (increase of FGF-27 and decrease of NGF8). Our microarray-based expression profiling revealed novel C3-regulated genes in SCs possibly involved in the axonotrophic (regeneration promoting) effects of C3 and C3156â181. Detection of altered neurotrophic factor expression by C3 or C3156â181 treated primary neonatal rat SCs and primary adult human SCs supports this hypothesis.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Astrid Rohrbeck, Frank Stahl, Markus Höltje, Timo Hettwer, Patrick Lindner, Sandra Hagemann, Andreas Pich, Kirsten Haastert-Talini,